Recursion Pharmaceuticals Inc (RXRX)
5.695
-0.06
(-0.96%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.06
(+0.97%)
After-Hours: 20:00
Recursion Pharmaceuticals Gross Profit Margin (Quarterly): 53.69% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 53.69% |
| June 30, 2024 | 36.14% |
| March 31, 2024 | 17.23% |
| December 31, 2023 | 6.99% |
| September 30, 2023 | -7.67% |
| June 30, 2023 | 14.83% |
| Date | Value |
|---|---|
| March 31, 2023 | -2.59% |
| December 31, 2022 | 20.74% |
| September 30, 2022 | -18.05% |
| June 30, 2022 | -85.90% |
| March 31, 2022 | -47.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-85.90%
Minimum
Jun 2022
53.69%
Maximum
Sep 2024
-1.07%
Average
6.99%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Revance Therapeutics Inc | 70.55% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.32% |
| Return on Assets | -56.47% |
| Return on Invested Capital | -76.30% |
| Profit Margin (Quarterly) | -367.5% |
| Operating Margin (Quarterly) | -377.1% |
| Return on Net Operating Assets | -166.5% |